Epigenome-wide association study of attention-deficit/hyperactivity disorder in adults
Paula Rovira, Cristina Sánchez‐Mora, Mireia Pagerols, Vanesa Richarte, Montserrat Corrales, Christian Fadeuilhe, Laura Vilar‐Ribó, Lorena Arribas, Gemma Shireby, Eilís Hannon, Jonathan Mill, Miguel Casas, Josep Antoni Ramos‐Quiroga, María Soler Artigas, Marta Ribasés
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder that often persists into adulthood. There is growing evidence that epigenetic dysregulation participates in ADHD. Given that only a limited number of epigenome-wide association studies (EWASs) of ADHD have been conducted so far and they have mainly focused on pediatric and population-based samples, we performed an EWAS in a clinical sample of adults with ADHD. We report one CpG site and four regions differentially methylated between patients and controls, which are located in or near genes previously involved in autoimmune diseases, cancer or neuroticism. Our sensitivity analyses indicate that smoking status is not responsible for these results and that polygenic risk burden for ADHD does not greatly impact the signatures identified. Additionally, we show an overlap of our EWAS findings with genetic signatures previously described for ADHD and with epigenetic signatures for smoking behavior and maternal smoking. These findings support a role of DNA methylation in ADHD and emphasize the need for additional efforts in larger samples to clarify the role of epigenetic mechanisms on ADHD across the lifespan.